Oppenheimer & Co’s IN8bio INAB Stock Holding History

Oppenheimer & Co’s Portfolio INAB Stock Details INAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$88.9K	Buy	63,042 +39,009	+162%	+$58.8K	﹤0.01%	1725
2026 Q1	$35.6K	Buy	+24,033	New	+$46.5K	﹤0.01%	1672

Oppenheimer & Co's INAB Position: Q2 2026 in Review

Oppenheimer & Co increased its IN8bio (INAB) stake by 162% in Q2 2026, buying an estimated $58.8K and bringing the position to 63,042 shares worth $88.9K. The position accounts for ﹤0.01% of the portfolio, ranked #1725.

Oppenheimer & Co first reported a position in INAB in Q1 2026 and has held it in 2 quarters since. 1 fund tracked by Wall St. Rank holds INAB as of Q2 2026.

Oppenheimer & Co held 63,042 shares of IN8bio worth $88.9K as of Q2 2026.
Oppenheimer & Co bought 39,009 IN8bio shares in Q2 2026, an estimated $58.8K.
IN8bio made up ﹤0.01% of Oppenheimer & Co's portfolio in Q2 2026, its #1725 holding.
Oppenheimer & Co first reported a position in IN8bio in Q1 2026 and has held it in 2 quarters since.
1 fund tracked by Wall St. Rank held IN8bio as of Q2 2026.

Based on Oppenheimer & Co's 13F filing for Q2 2026, filed 3 Aug 2026.